Unlock stock picks and a broker-level newsfeed that powers Wall Street.
90.01
+4.07
+(4.74%)
At close: April 2 at 4:00:01 PM EDT
86.50
-3.51
(-3.90%)
Pre-Market: 7:02:58 AM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 6 | 6 | 7 | 8 |
| Avg. Estimate | -0.34 | -0.47 | -1.28 | 1.41 |
| Low Estimate | -0.9 | -0.71 | -2.45 | 0.03 |
| High Estimate | 0.48 | -0.22 | -0.83 | 3.03 |
| Year Ago EPS | -1.32 | -0.8 | -3.83 | -1.28 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 18 | 18 | 20 | 20 |
| Avg. Estimate | 158.31M | 175.97M | 727.64M | 964.42M |
| Low Estimate | 145.2M | 152M | 697.74M | 853M |
| High Estimate | 236M | 247.12M | 813.99M | 1.06B |
| Year Ago Sales | 96.12M | 138.16M | 508.82M | 727.64M |
| Sales Growth (year/est) | 64.71% | 27.37% | 43.00% | 32.54% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -1.67 | -1.25 | -0.96 | -0.71 |
| EPS Actual | -1.32 | -0.8 | -0.89 | -0.79 |
| Difference | 0.35 | 0.46 | 0.07 | -0.08 |
| Surprise % | 20.93% | 36.53% | 7.40% | -10.63% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.34 | -0.47 | -1.28 | 1.41 |
| 7 Days Ago | -0.34 | -0.47 | -1.28 | 1.41 |
| 30 Days Ago | -0.34 | -0.47 | -1.28 | 1.41 |
| 60 Days Ago | -0.56 | -0.44 | -0.94 | 1.96 |
| 90 Days Ago | -0.56 | -0.43 | -0.84 | 2.1 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 2 | 2 | -- | -- |
| Up Last 30 Days | 2 | 1 | -- | -- |
| Down Last 7 Days | 2 | 2 | -- | -- |
| Down Last 30 Days | 2 | 3 | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| BPMC | 74.37% | 40.57% | 66.58% | 210.28% |
| S&P 500 | 6.69% | 6.80% | 9.98% | 14.34% |
Upgrades & Downgrades
| Initiated | Jefferies: Buy | 3/17/2025 |
| Initiated | Scotiabank: Sector Outperform | 3/7/2025 |
| Reiterates | Citizens Capital Markets: Market Outperform to Market Outperform | 3/3/2025 |
| Reiterates | JMP Securities: Market Outperform to Market Outperform | 2/14/2025 |
| Reiterates | Needham: Buy to Buy | 2/14/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 2/14/2025 |
Related Tickers
NUVL Nuvalent, Inc.
70.46
+3.62%
KYMR Kymera Therapeutics, Inc.
26.36
+4.46%
BBIO BridgeBio Pharma, Inc.
34.62
+4.85%
RARE Ultragenyx Pharmaceutical Inc.
35.37
+4.52%
BCYC Bicycle Therapeutics plc
8.05
+2.55%
COGT Cogent Biosciences, Inc.
5.72
-1.21%
ARGX argenx SE
583.62
+2.91%
SRRK Scholar Rock Holding Corporation
32.54
+8.25%
APLS Apellis Pharmaceuticals, Inc.
23.00
+1.41%
INSM Insmed Incorporated
73.44
+2.00%